6,12-Dihydro-1-benzopyrano [3,4-b] [1,4] benzothiazin-6-ones: Synthesis and mdr reversal in tumor cells

Anticancer Research

Volumn 18, Issue 4 C, 1998, Pages 3001-3004

  Shah, Anamik ^a   Naliapara, Yogesh ^a   Sureja, Dinesh ^a   Motohashi, Noboru ^b   Kawase, Masami ^c   Miskolci, Csilla ^d   Szabo, Diana ^d   Molnár, Joseph ^d  

^a SAURASHTRA UNIVERSITY   (India)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c JOSAI UNIVERSITY   (Japan)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

6,12 Dihydro 1 benzopyrano 3,4 b 1,4 benzothiazin 6 ones; mdr reversal on tumor cells

Indexed keywords

BENZOTHIAZINE DERIVATIVE; COUMARIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; COUMARINS; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; LYMPHOMA, T-CELL; MICE; PLASMIDS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZINES; TUMOR CELLS, CULTURED;

EID: 0031865744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Motohashi N: Test for antitumor activities of phenothiazines and phenoxazines. (in Japanese) Yakugaku Zasshi 103: 364-371, 1983; Chem Abst 99: 231v, 1983.
2. Motohashi N: Test for antitumor activities of phenothiazines and phenoxazines. (in Japanese) Yakugaku Zasshi 103: 364-371, 1983; Chem Abst 99: 231v, 1983.
3. Motohashi N, Sakagami H, Kamata K and Yamamoto Y: Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives. Anticancer Res 11: 1933-1938, 1991.
4. Szabó M, Csiszár J, Rausch H, Molnár J and Motohashi N: Influence of benzo[a]phenothiazines on the element content of two tobacco tissue cultures differing in hormone requirement. Anticancer Res 17: 2049-2056, 1997.
5. Shah A, Naliapara Y, Sureja D, Motohashi N, Kurihara T, Kawase M, Satoh K, Sakagami H and Molnár J: Biological activity of 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones. Anticancer Res 18: in press, 1998.
6. Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GWA, Pommier Y and Burke TR: Coumarin-based inhibitors of HIV integrase. J Med Chem 40: 242-249, 1997.
7. Shah VR, Bose JL and Shah RC: New synthesis of 4-hydroxycoumarins. J Org Chem 25: 677-678, 1960.
8. Shah AK, Bhatt NS, Raval RV and Thakor VM: Synthesis of 4-hydroxycoumarins. Curr Sci 53: 1241-1242, 1984.
9. Ziegler E and Junek H: A new synthesis of 4-hydroxycoumarin and its derivatives. Monatsch Chem 86: 29-38, 1955.
10. Shah A: Ph.D. Thesis, Saurashta University, Rajkot, 1982.
11. Tabakovic K, Tabakovic I, Trkovnik M, Juric A and Trinajstic N: Studies on novel heterocyclic ring systems. Reaction of 4-hydroxycoumarin with o-aminobenzaldehyde and 2-mercaptoaniline. J Heterocyclic Chem 17: 801-803, 1980.
12. Motohashi N, Sakagami H, Kurihara T, Csuri K and Molnár J: Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 12: 135-140, 1992.
13. Molnár J, Kiraly J and Mandi Y: The antibacterial action and R-factor inhibiting activity by chlorpromazine. Experimentia 31: 444-445, 1975.
14. Weaver JL, Szabo G, Pine PS, Gottesman MM, Goldenberg S and Aszalos A: The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int J Cancer 54: 456-461, 1993.
15. Kessel D: Exploring multidrug resistance using rhodamine 123. Cancer Commun 1: 145-149, 1989.
16. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J and Rosenberg SA: Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer Res 54: 1766-1771, 1994.